Lynparza Tablet, Film Coated
Product Images NDC 0310-0569
Product Visual Gallery
This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Lynparza (NDC 0310-0569). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Astrazeneca Pharmaceuticals Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Figure 1)
Figure 2 (Image 06)
Figure-3 (Figure 3)
Figure 3 (Image 02)
Figure 4 (Image 07)
Figure-6 (Figure 6)
Figure-7 (Figure 7)
Figure-8 (Image 04)
Figure-9 (Image 05)
Figure_10 (Figure 10)
Figure 11 (Figure 8)
Figure-12 (Figure 12)
Figure-13 (Figure 13)
Lynparza_100mg_60tablet_bottle_label (Lynparza 100mg 60tablet Bottle Label)
Lynparza_150mg_120_tablet_bottle_label (Lynparza 150mg 120tablet Bottle)
100_mg (100)
150_mg (150)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.